Clinical Trial: Study on the Regulation of the Response to Concurrent Chemoradioimmunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma by Oral-Blood Microecology via Peripheral Blood Immune Cells (China)

Posted On: 2026-08-18

China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Regulation of the Response to Concurrent Chemoradioimmunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma by Oral-Blood Microecology via Peripheral Blood Immune Cells'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130192

Registration Time: 2026/08/17

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Henan University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=308317

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Study on the Regulation of the Response to Concurrent Chemoradioimmunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma by Oral-Blood Microecology via Peripheral Blood Immune Cells (China)